These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Intravenous human recombinant tumor necrosis factor receptor p55-Fc IgG1 fusion protein Ro 45-2081 (lenercept): a double blind, placebo controlled dose-finding study in rheumatoid arthritis. Rau R; Sander O; van Riel P; van de Putte L; Hasler F; Zaug M; Kneer J; van der Auwera P; Stevens RM; J Rheumatol; 2003 Apr; 30(4):680-90. PubMed ID: 12672184 [TBL] [Abstract][Full Text] [Related]
6. Autologous hemopoietic stem cell transplantation in severe rheumatoid arthritis: a report from the EBMT and ABMTR. Snowden JA; Passweg J; Moore JJ; Milliken S; Cannell P; Van Laar J; Verburg R; Szer J; Taylor K; Joske D; Rule S; Bingham SJ; Emery P; Burt RK; Lowenthal RM; Durez P; McKendry RJ; Pavletic SZ; Espigado I; Jantunen E; Kashyap A; Rabusin M; Brooks P; Bredeson C; Tyndall A J Rheumatol; 2004 Mar; 31(3):482-8. PubMed ID: 14994391 [TBL] [Abstract][Full Text] [Related]
7. Treatment of rheumatoid arthritis with a DR4/1 peptide. St Clair EW; Cohen SB; Lee ML; Fleischmann RM; Lee SH; Moreland LW; Olsen NJ; Pratt PW; Yocum DE; Heck L; Winkelhake J; Holcenberg JS; Shulman MJ J Rheumatol; 2000 Aug; 27(8):1855-63. PubMed ID: 10955324 [TBL] [Abstract][Full Text] [Related]
8. [The effect of dietotherapy on the clinico-immunological indices of rheumatoid arthritis patients]. Sharafetdinov KhKh; Denisov LN; Samsonov GR; Pokrovskaia GR; Voĭtko NE Vopr Pitan; 1990; (1):18-22. PubMed ID: 2346005 [TBL] [Abstract][Full Text] [Related]
9. High dose versus low dose fludarabine in the treatment of patients with severe refractory rheumatoid arthritis. Davis JC; Fessler BJ; Tassiulas IO; McInnes IB; Yarboro CH; Pillemer S; Wilder R; Fleisher TA; Klippel JH; Boumpas DT J Rheumatol; 1998 Sep; 25(9):1694-704. PubMed ID: 9733448 [TBL] [Abstract][Full Text] [Related]
10. Treatment of rheumatoid arthritis by immunization with mononuclear white blood cells: results of a preliminary trial. Smith JB; Fort JG J Rheumatol; 1996 Feb; 23(2):220-5. PubMed ID: 8882022 [TBL] [Abstract][Full Text] [Related]
11. A randomized, open-label, comparative, 6-month trial of oral ultra-low doses of antibodies to tumor necrosis factor-alpha and diclofenac in rheumatoid arthritis. Dugina JL; Petrov VI; Babayeva AR; Martyushev-Poklad AV; Tcherevkova EV; Epstein OI; Sergeeva SA Int J Tissue React; 2005; 27(1):15-21. PubMed ID: 15847101 [TBL] [Abstract][Full Text] [Related]
12. Dose escalation of parenteral methotrexate in active rheumatoid arthritis that has been unresponsive to conventional doses of methotrexate: a randomized, controlled trial. Lambert CM; Sandhu S; Lochhead A; Hurst NP; McRorie E; Dhillon V Arthritis Rheum; 2004 Feb; 50(2):364-71. PubMed ID: 14872477 [TBL] [Abstract][Full Text] [Related]
13. Combination therapy in recent onset rheumatoid arthritis: a randomized double blind trial of the addition of low dose cyclosporine to patients treated with low dose chloroquine. van den Borne BE; Landewé RB; Goei The HS; Rietveld JH; Zwinderman AH; Bruyn GA; Breedveld FC; Dijkmans BA J Rheumatol; 1998 Aug; 25(8):1493-8. PubMed ID: 9712089 [TBL] [Abstract][Full Text] [Related]
14. A randomised, blinded, placebo-controlled, dose escalation study of the tolerability and efficacy of filgrastim for haemopoietic stem cell mobilisation in patients with severe active rheumatoid arthritis. Snowden JA; Biggs JC; Milliken ST; Fuller A; Staniforth D; Passuello F; Renwick J; Brooks PM Bone Marrow Transplant; 1998 Dec; 22(11):1035-41. PubMed ID: 9877264 [TBL] [Abstract][Full Text] [Related]
15. Efficacy of roxithromycin in adult patients with rheumatoid arthritis who had not received disease-modifying antirheumatic drugs: a 3-month, randomized, double-blind, placebo-controlled trial. Ogrendik M Clin Ther; 2009 Aug; 31(8):1754-64. PubMed ID: 19808134 [TBL] [Abstract][Full Text] [Related]
16. Diclofenac combined with cyclosporine in treatment refractory rheumatoid arthritis: longitudinal safety assessment and evidence of a pharmacokinetic/dynamic interaction. Kovarik JM; Kurki P; Mueller E; Guerret M; Markert E; Alten R; Zeidler H; Genth-Stolzenburg S J Rheumatol; 1996 Dec; 23(12):2033-8. PubMed ID: 8970037 [TBL] [Abstract][Full Text] [Related]